Approximate cumulative risks of HF by MLVD and whether treatment with anthracyclines was given. Modeled cumulative risk of HF as first cardiac event among 5-year survivors of HL by time since initial HL treatment of categories of MLVD (Gy). Lines indicate estimated cumulative incidences for dose categories (0-15 Gy, 16-20 Gy, and ≥21 Gy) with and without anthracycline exposure. Cumulative risks were calculated with other heart disease or death as a competing risk. Further details are given in supplemental Text 3.